Press release
Transdermal Medical Patch Market Demand and Growth Opportunities Detailed Analysis Report 2024-2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Transdermal Medical Patch Market- (By Type (Single Drug-in-Adhesive, Multi-layer Drug-in Adhesive, Reservoir, Vapor Patch, Matrix), By Application (Neurologic conditions, Pain Management, Nicotine Cessation, Cardiovascular Disorders, Hormonal Therapy, others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."According to the latest research by InsightAce Analytic, the Global Transdermal Medical Patch Market is valued at US$ 8.15 Bn in 2022, and it is expected to reach US$ 11.86 Bn by 2031, with a CAGR of 4.3% during a forecast period of 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2115
A transdermal patch refers to a pharmaceutical adhesive patch that is administered by applying it onto the surface of the skin. Over a period of time, the human body undergoes the process of absorbing the drug contained within the patch. Certain individuals may perceive the utilisation of a transdermal patch as a more convenient alternative to the ingestion of oral medication or the administration of injections. Transdermal patches refer to adhesive patches designed to provide medication directly through the skin.
This, in turn, will create enormous chances for the transdermal medical Patch market to expand. As a result, the need for transdermal medical patches is expected to increase. However, the infrastructure required for transdermal patches is costly and requires specialized equipment, skilled labour, and advanced technology. Introducing new technology and sustained Economic growth indicate the transdermal medical patch market's future growth. Businesses in the market are ramping up their operations by inventing cutting-edge technologies or expanding into developing nations, ultimately increasing competition and boosting the market growth.
List of Prominent Players in the Transdermal Medical Patch Market:
• Hisamitsu Pharmaceutical co inc
• Medline Industries LP
• Johnson & Johnson
• Novartis AG
• Teva Pharmaceutical Industries Ltd
• UCB SA
• Viatris Inc
• Endo Pharmaceutical Inc
• Boehringer ingelheim international GmbH
• Corium LLC
• Luye Pharma Group
• Teikoku Pharma
• Samyang Holdings Corporation
• Gedeon Richter PLC
• AdhexPharma
• Sparsha Pharma International Pvt Ltd.
Market Dynamics:
Drivers-
Growing demand for transdermal medical patches can be attributed to the accelerated expansion of the market for nicotine transdermal patches. In addition, e-cigarettes are the most frequently used tobacco product among high school and middle school kids from the same source, followed by pipes, cigars, smokeless pipes, cigarettes, heated tobacco products, and pipe tobacco, fueling the expansion of the transdermal medical patch industry.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Challenges:
The prime challenge is the high cost, rising skin irritation, and adopting cutting-edge technology, hindering the development of the transdermal medical patch business because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the transdermal medical patch market. However, the rising prevalence of contact dermatitis and other skin diseases at the place of application prevents the skin from absorbing various drugs. Skin's decreasing capacity to absorb various medications and an increase in the danger of contact dermatitis or other skin diseases at the application site are two factors that can impede growth.
The COVID-19 pandemic has had a significant effect on daily life. Testing, treatment, and immunization were prioritized during the pandemic because they were seen as the most immediately problematic responses. To prioritise individuals with COVID-19, non-critical medical procedures and treatments were frequently postponed or reduced. This may have affected the need for medical patches in general, especially for less urgent uses.
Regional Trends:
The North American transdermal medical patch market is anticipated to register a major market share in revenue. It is projected to grow at a high CAGR in the near future because of healthcare infrastructure, market dominance of key businesses, and an increasing number of studies being conducted here. In addition, sustained economic expansion will fuel further advancements in the transdermal medical patch industry across the region.
Besides, Europe had a considerable share in the market due to its developed economy, rapidly expanding population, and the availability of huge unexplored markets, a vast population pool, and a rising need for quality healthcare have all contributed to the region's rapid economic development in recent years. Moreover, the existence of significant market players and the growing cooperation between major players for market penetration in the area enables an opportunity to grow the global transdermal medical patch market.
Recent Developments:
• In June 2023, Teikoku Pharma's dexmedetomidine transdermal device was granted a fast-track designation by the US FDA. The transdermal method developed by the business was utilised to administer dexmedetomidine for a duration of four days to effectively manage chronic pain.
• In March 2022, Corium, a biopharmaceutical business, disclosed that the FDA has granted approval for the usage of Adlarity in the treatment of individuals afflicted with varying degrees of dementia linked to Alzheimer's disease.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2115
Segmentation of Transdermal Medical Patch Market-
By Type-
• Single Drug-in-Adhesive
• Multi-layer Drug-in Adhesive
• Reservoir
• Vapor Patch
• Matrix
By Application-
• Neurologic conditions
• Pain Management
• Nicotine Cessation
• Cardiovascular Disorders
• Hormonal Therapy
• others
By Distribution Channel-
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2115
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transdermal Medical Patch Market Demand and Growth Opportunities Detailed Analysis Report 2024-2031 here
News-ID: 3826375 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd
CDMO Market Enters a New Strategic Growth Cycle
The global Contract Development and Manufacturing Organization (CDMO) industry is undergoing a fundamental transformation, evolving from a traditional outsourcing function into a strategic pillar of pharmaceutical and biotechnology innovation worldwide.
As drug development becomes more complex, capital-intensive, and time-sensitive, CDMOs are no longer viewed as external vendors - they are increasingly becoming integrated partners in the drug lifecycle, supporting everything from early-stage development to large-scale commercial manufacturing.
InsightAce Analytic Pvt. Ltd. has…
The AI Revolution Is Here - And the Data Proves It
A $2.6 Trillion Market in Motion: Why C-Suite Leaders Cannot Afford to Wait
Artificial intelligence is no longer a future-state technology - it is the operating reality reshaping every sector of the global economy. According to InsightAce Analytic's flagship Artificial General Intelligence (AGI) Market Report, the AGI market alone is valued at USD 5.24 billion in 2025 and is projected to surge to USD 82.06 billion by 2035, growing at a…
Sustainable Packaging Market Strategic Industry Overview and Forecast 2026 to 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Sustainable Packaging Market Size, Share & Trends Analysis Report By Material (Paper & Paperboard, Plastic, Metal, Glass), Process (Recycled, Reusable, Degradable), Function (Active, Molded Pulp, Alternate Fiber), Application (Food & Beverage, Healthcare, Others) & Layer (primary, secondary, and tertiary)- Market Outlook And Industry Analysis 2034"
The global Sustainable Packaging Market is estimated to reach over USD…
SCADA Market Insights Highlighting Technological Advancements in Wireless Sensor …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global SCADA Market Size, Share & Trends Analysis Report By Offering (Hardware, Software, Services), Component (Programmable Logic Controller, Remote Terminal Unit, Human-Machine Interface), End User (Process Industries, Discrete Manufacturing, Utilities), Region, Market Outlook And Industry Analysis 2034"
The global SCADA market is estimated to reach over USD 25.0 billion by the year 2034, exhibiting a CAGR of…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
